Patent · US Active

P2X7 modulators and methods of use

US10112937B2 · kind B2 · utility

10Cited by

23References

40Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Manuel Jesus Alcazar Vaca · Toledo, ES
Brett D. Allison · Del Mar, US
Jose Ignacio Andres Gil · Madrid, ES
Christa C. Chrovian · Village of La Jolla, US
Heather R. Coate · San Diego, US
Meri De Angelis · Munich, DE
Xiaohu Deng · San Diego, US
Curt A. Dvorak · Poway, US
Christine F. Gelin · San Diego, US
Michael A. Letavic · San Diego, US
Jimmy T. Liang · San Diego, US
Neelakandha S. Mani · San Diego, US
Jason C. Rech · San Diego, US
Brad M. Savall · San Diego, US
Akinola Soyode-Johnson · San Diego, US
Brice M. Stenne · Village of La Jolla, US
Devin M. Swanson · Carlsbad, US
Jessica L. Wall · San Diego, US

Key dates

Filing date	Mar 14, 2014
Grant date	Oct 30, 2018
Priority date	—
Expiry date	Mar 14, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to compounds of Formulas (I, Ia, IIa and IIb). The invention also relates to pharmaceutical compositions comprising compounds of Formulas (I, Ia, IIa and IIb). Methods of making and using the compounds of Formulas (I, Ia, IIa and IIb) are also within the scope of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.